Saforax

Company Overview

Snapshot

Founded in January 2024, Saforax operates with 1–10 employees and is led by co-founder Yonatan Hayoun. The company is currently in the Pre-Funding stage, focusing on developing its innovative medical device.

Business overview

Saforax (Safe-for-Thorax) is a Health Tech & Life Sciences company specializing in medical devices, particularly in the Life Support sector. The company develops an innovative medical device designed to transform chest drainage procedures, making them accessible at the point of injury to lower-skilled practitioners. Saforax addresses the critical need for rapid, safe intervention in chest injuries, serving markets in Europe and North America, with a focus on both military and civilian settings, including first responders, hospitals, and the broader medical device industry.

Company Intelligence Q&A

What is the primary product developed by Saforax?

Saforax develops a medical device called Saforax (Safe-for-Thorax), designed to simplify chest tube insertion and make chest decompression accessible to lower-skilled practitioners at the point of injury.

When was Saforax founded?

Saforax was founded in January 2024.

Which markets does Saforax target?

Saforax targets markets in Europe and North America, aiming to improve trauma care and chest tube insertion in both military and civilian settings.

What problem does Saforax aim to solve?

Saforax aims to address the critical need for rapid and safe intervention in chest injuries, which are a leading cause of preventable death in combat, by enabling lower-trained personnel to perform chest decompression effectively.

Who are the founders of Saforax?

Yonatan Hayoun is a co-founder of Saforax, serving as the CTO.